Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefcapene pivoxil hydrochloride granules vs cefdinir in pediatric acute respiratory bacterial infections
CTR20243816Phase 4Active
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefcapene pivoxil in pharyngitis, acute tonsillitis, laryngitis, acute bronchitis, bacterial pneumonia, sponsored by Shionogi & Co., Ltd.. Started Jan 2025; status: active.
02
Drugs
cefcapene pivoxil
03
Conditions
pharyngitisacute tonsillitislaryngitisacute bronchitisbacterial pneumonia
Beyond the preview
Go deeper on CTR20243816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243816.